S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
S&P 500   4,569.78 (-0.54%)
DOW   36,204.44 (-0.11%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

Uniphar Share Price, News & Analysis (LON:UPR)

GBX 185
0.00 (0.00%)
(As of 12/4/2023 ET)
Compare
Today's Range
185
▼
188
50-Day Range
180
▼
218
52-Week Range
178
▼
334
Volume
5,257 shs
Average Volume
29,755 shs
Market Capitalization
£505.09 million
P/E Ratio
1,321.43
Dividend Yield
1.08%
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades

UPR stock logo

About Uniphar Stock (LON:UPR)

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which offers access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that provides bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

UPR Stock Price History

UPR Stock News Headlines

November 20, 2023 | lse.co.uk
Uniphar Plc Share Price (UPR.IE)
December 5, 2022 | finance.yahoo.com
Edited Transcript of UPR.I earnings conference call or presentation 30-Aug-22 8:00am GMT
December 4, 2023 | Wealthpress (Ad)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
October 16, 2022 | finance.yahoo.com
Uniphar plc (UPR.L)
September 25, 2022 | marketwatch.com
Unsaturated Polyester Resins (UPR) Market 2022 : Future Developments, Key Vendors, Regional Analysis and Industry Scope by 2027
September 6, 2022 | barrons.com
Uniphar PLC
September 1, 2022 | proactiveinvestors.com.au
FTSE 100 closes lower again as pound scrapes long-term lows
July 19, 2022 | investing.com
Uniphar Group PLC (UPR)
December 4, 2023 | Wealthpress (Ad)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
August 21, 2021 | proactiveinvestors.com
Uniphar PLC - Holding(s) in Company
July 29, 2021 | markets.businessinsider.com
Uniphar PLC : Half Year Trading Update and Notice of Results
July 23, 2021 | markets.businessinsider.com
Uniphar PLC : Acquisition of CoRRect Medical GmbH
July 20, 2021 | venturebeat.com
MedTech VC Firm 415 CAPITAL Announces Strategic Alliance With European Healthcare Service Provider Uniphar Group PLC
February 2, 2021 | lse.co.uk
Blackfinch Spr. Regulatory News
November 23, 2020 | finance.yahoo.com
What Is Uniphar's (ISE:UPR) P/E Ratio After Its Share Price Rocketed?
See More Headlines
Receive UPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/20 Dividend
9/28/2023
Dividend Payable
10/20/2023
Today
12/04/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Distribution
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:UPR
CUSIP
N/A
CIK
N/A
Web
www.uniphar.ie
Phone
353 1 428 7777
Fax
N/A
Employees
2,800
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX 0.14
Trailing P/E Ratio
1,321.43
Forward P/E Ratio
10.36
P/E Growth
N/A
Net Income
£44.54 million
Net Margins
1.92%
Pretax Margin
N/A
Return on Equity
16.89%
Return on Assets
4.24%

Debt

Debt-to-Equity Ratio
122.49
Current Ratio
0.95
Quick Ratio
0.60

Sales & Book Value

Annual Sales
£2.32 billion
Price / Sales
0.22
Cash Flow
GBX 18.56 per share
Price / Cash Flow
9.97
Book Value
GBX 111 per share
Price / Book
1.67

Miscellaneous

Outstanding Shares
273,020,000
Free Float
N/A
Market Cap
£505.09 million
Optionable
Not Optionable
Beta
0.73
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Gerard Rabbette B.Comm FCA
    CEO & Executive Director
  • Mr. Timothy Dolphin B.Comm FCA
    CFO & Executive Director
  • Mr. Allan Smylie C.F.A.
    Head of Strategy and Investor Relations
  • Ms. Aisling McCarthy
    General Counsel & Company Secretary
  • Mr. Seamus Egan
    Head of Corporate Development
  • Mr. Padraic Dempsey
    Chief Commercial Officer
  • Mr. Brian O'Shaughnessy
    CCO and Commercial Lead of C&C Pharma & Product Access
  • Mr. Dermot Ryan
    Managing Director
  • Ms. Kay Bonavita
    Chief Commercial Officer for Uniphar Logistics
  • Rick Hughes
    Managing Director of Uniphar Logistics

Key Competitors

View All Competitors














UPR Stock Analysis - Frequently Asked Questions

Should I buy or sell Uniphar stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Uniphar in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UPR shares.
View UPR analyst ratings or view top-rated stocks.

How have UPR shares performed in 2023?

Uniphar's stock was trading at GBX 267.50 at the beginning of 2023. Since then, UPR stock has decreased by 30.8% and is now trading at GBX 185.
View the best growth stocks for 2023 here.

How often does Uniphar pay dividends? What is the dividend yield for Uniphar?

Uniphar announced a dividend on Thursday, September 14th. Stockholders of record on Thursday, September 28th will be paid a dividend of GBX 0.01 per share on Friday, October 20th. This represents a yield of 0.24%. The ex-dividend date of this dividend is Thursday, September 28th. The official announcement can be seen at this link.
Read our dividend analysis for UPR.

Is Uniphar a good dividend stock?

Uniphar (LON:UPR) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 0.82%. The dividend payout ratio is 1,428.57%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for UPR.

How do I buy shares of Uniphar?

Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:UPR) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -